Heart Test Labs Delisted from Nasdaq
Ticker: HSCSW · Form: 8-K · Filed: May 10, 2024 · CIK: 1468492
| Field | Detail |
|---|---|
| Company | Heart Test Laboratories, Inc. (HSCSW) |
| Form Type | 8-K |
| Filed Date | May 10, 2024 |
| Risk Level | high |
| Pages | 6 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.001, $1, $0.10, $425, $4 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, nasdaq, compliance
Related Tickers: HSCS
TL;DR
Heart Test Labs got kicked off Nasdaq, stock and warrants delisted effective May 6th.
AI Summary
Heart Test Laboratories, Inc. filed an 8-K on May 10, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's common stock and warrants were delisted from the Nasdaq Capital Market, effective May 6, 2024, due to failure to meet certain listing requirements.
Why It Matters
The delisting from Nasdaq means Heart Test Laboratories' securities will no longer be traded on a major exchange, potentially impacting liquidity and investor confidence.
Risk Assessment
Risk Level: high — Delisting from a major stock exchange like Nasdaq indicates significant financial distress or non-compliance, posing a substantial risk to investors.
Key Players & Entities
- Heart Test Laboratories, Inc. (company) — Registrant
- Nasdaq Capital Market (company) — Exchange from which delisted
- May 6, 2024 (date) — Effective date of delisting
- May 10, 2024 (date) — Filing date of the 8-K
FAQ
What specific listing requirements did Heart Test Laboratories fail to meet to be delisted from Nasdaq?
The filing states the delisting is due to failure to satisfy a continued listing rule or standard, but does not specify which particular rule was violated.
When was the delisting from the Nasdaq Capital Market effective?
The delisting was effective as of the close of business on May 6, 2024.
What securities of Heart Test Laboratories were delisted?
Both the company's common stock and warrants were delisted from the Nasdaq Capital Market.
Where will Heart Test Laboratories' securities be traded now, if anywhere?
The filing does not specify where the securities will be traded after delisting from Nasdaq; they may move to over-the-counter markets or cease public trading.
What is the significance of filing an 8-K for a delisting event?
An 8-K filing is required to promptly inform the public and the SEC about material events, such as a company's delisting from a stock exchange.
Filing Stats: 1,919 words · 8 min read · ~6 pages · Grade level 14.5 · Accepted 2024-05-10 16:15:44
Key Financial Figures
- $0.001 — id price of the Company's common stock, $0.001 par value per share (the "Common Stock"
- $1 — ment to maintain a minimum bid price of $1 per share (the "Minimum Bid Price Requi
- $0.10 — Common Stock had a closing bid price of $0.10 or less for at least ten consecutive tr
- $425 — ly following the Reverse Stock Split is $425.00, which equals the product of 100 mul
- $4 — equals the product of 100 multiplied by $4.25, the exercise price per share immedi
Filing Documents
- ea0205776-8k_heart.htm (8-K) — 57KB
- ea020577601ex3-1_heart.htm (EX-3.1) — 8KB
- ex3-1_001.jpg (GRAPHIC) — 161KB
- ex3-1_002.jpg (GRAPHIC) — 374KB
- ex3-1_003.jpg (GRAPHIC) — 134KB
- ex3-1_004.jpg (GRAPHIC) — 53KB
- 0001213900-24-041736.txt ( ) — 1281KB
- hscs-20240506.xsd (EX-101.SCH) — 3KB
- hscs-20240506_def.xml (EX-101.DEF) — 26KB
- hscs-20240506_lab.xml (EX-101.LAB) — 36KB
- hscs-20240506_pre.xml (EX-101.PRE) — 25KB
- ea0205776-8k_heart_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEART TEST LABORATORIES, INC. Date: May 10, 2024 By: /s/ Andrew Simpson Name: Title: Andrew Simpson President, Chief Executive Officer, and Chairman of the Board of Directors 3